ASHLEY SUTTON: Open Payments
NPI 1891236709 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 21 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $530 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| ABBVIE INC. | 4 | $64 |
| UCB, Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Botanix SB Inc | 1 | $17 |
Products named: COSENTYX, Bimzelx, TREMFYA, RINVOQ, DUPIXENT, EUFLEXXA, LIBTAYO, ILUMYA.
Industry payments across KY — which companies pay providers there.
